A recombinant Mycobacterium smegmatis-based surface display system for developing the T cell-based COVID-19 vaccine.
Hum Vaccin Immunother
; 19(1): 2171233, 2023 12 31.
Article
in En
| MEDLINE
| ID: mdl-36785935
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mycobacterium smegmatis
/
COVID-19
Limits:
Animals
/
Humans
Language:
En
Journal:
Hum Vaccin Immunother
Year:
2023
Type:
Article
Affiliation country:
China